OneStart: Your chance to win £100k to realise your biotech business idea
Do you have an idea to solve a critical problem healthcare? Or do you have the scientific or business know-how to help someone else develop their idea?
The Oxbridge Biotech Roundtable (OBR) and SR One, the venture capital arm of GlaxoSmithKline, have teamed up again for the OneStart competition – the largest biotech startup accelerator programme in the world – to offer young innovators from all disciplines the chance to win £100k with free lab space at Stevenage Bioscience Catalyst near London, and ongoing legal and business advice from our sponsors to transform their ideas into a successful business.
Applications are now open until 1st December 2014. To learn more about the programme and start building your team, visit www.oxbridgebiotech.com/onestart.
Who should participate?
- Science/medical students and researchersinterested in spinning out their research or commercializing their ideas
- Business students and young professionalskeen to get involved in the biotech and healthcare industries
- Software developers and engineersinterested in contributing their technical skills to realising a product
- Anyone interested in entrepreneurship
You do not need to have a team yet, or even have your own idea, as you can register now at our Co-founder Hub (and Discussion Forum) to find teammates to complement your strengths, show your interest to join other teams.
Ideas at all stages of development are welcome. All semi-finalists will be directly mentored by experienced industry professionals for at least six weeks, and invited to attend a biotech business bootcamp in London in February 2015 with workshops from our global sponsors, including SR One, Johnson & Johnson Innovation, Roche, McKinsey, and others.
We look forward to meeting you in person or via www.oxbridgebiotech.com/onestart.
If you have any questions at all, please do get in touch via sybil.wong@oxbridgebiotech.com. We would be happy to answer your questions about OneStart and help you move science forward to benefit human health
